DMSO Cream Is a Formulation, Not Proof of Pain Relief

DMSO cream is dimethyl sulfoxide in a cream base. That description does not establish what the product treats, whether its concentration matches a clinical study, or whether the finished formulation has been tested.

For ordinary joint or muscle pain, the useful conclusion is that evidence for DMSO cream is limited and inconsistent. DMSO’s ability to penetrate skin also makes the cream’s other ingredients—and substances already on the skin—part of the safety question.

“DMSO cream” can describe very different products

A label may disclose DMSO as a percentage, list it without an amount, or combine it with aloe, herbs or pain-relief drugs. Those products are not interchangeable.

Label feature	What it tells you	What it does not establish
DMSO concentration	How much DMSO the formula claims to contain	That the concentration is effective or appropriate for a condition
Basis of the percentage	Whether the amount is stated by weight or volume	How much reaches tissue or produces an effect
Cream base	Which other ingredients contact the skin	That those ingredients are clinically inert when used with DMSO
Added active ingredients	Whether another substance could contribute to an effect or reaction	That DMSO deserves credit for the result
“Pharmaceutical grade” or purity claim	The seller’s stated quality position	FDA approval of the cream or clinical testing of the finished product
Tube, jar or roller	How the product is dispensed	Dose, efficacy or safety

Cream, gel and liquid are different formulations. Evidence for a particular DMSO concentration in one base cannot automatically validate a DMSO gel, diluted liquid or multi-ingredient balm.

Does DMSO cream work for pain?

Osteoarthritis evidence does not establish dependable relief

A 2011 meta-analysis found only three eligible controlled osteoarthritis trials: two studied DMSO and one studied oral MSM, with 326 participants in total. The pooled difference was 6.34 mm on a 100-mm pain scale, and its 95% confidence interval crossed no effect. The reviewers considered the overall result neither statistically nor clinically significant and said definitive conclusions could not be drawn because findings were mixed and treatment periods inadequate (Brien et al., 2011).

Because that estimate combined DMSO and MSM, it is not a clean measurement of DMSO cream alone. It also does not prove that every DMSO cream is ineffective. It does show why a broad “arthritis cream” claim is not justified by this evidence: few trials qualified, products and comparators varied, and the combined result did not demonstrate meaningful pain relief.

The National Center for Complementary and Integrative Health gives a similarly cautious consumer assessment. Its DMSO and MSM summary says only a small amount of osteoarthritis research has been conducted and no conclusion can be reached about whether either substance helps (NCCIH). Our review of DMSO for pain explains why studies of diclofenac in a DMSO vehicle do not prove that DMSO alone relieves pain.

Specialized uses do not create a general-purpose treatment

Topical DMSO has also appeared in specialized protocols involving pressure ulcers, skin injury after leakage of certain chemotherapy drugs, and delivery of other topical agents. These findings concern particular formulations and clinical situations; they do not support treating an undiagnosed painful or damaged area at home (Capriotti and Capriotti, 2012).

DMSO’s established U.S. prescription use should not be confused with a retail cream. RIMSO-50 is a sterile 50% w/w solution placed into the bladder by catheter for symptomatic relief of interstitial cystitis. Its label says it has not been approved as safe and effective for any other indication (DailyMed). That approval is not authorization for a topical pain cream. See established DMSO uses in humans for the distinction.

Skin penetration is a feature and a risk

DMSO is used as a solvent and penetration enhancer. A dermatology review explains that it can disrupt barrier function in the outer skin layer, increase diffusion and improve the solubility and transport of other substances (Capriotti and Capriotti, 2012).

The complete exposure therefore matters. Cosmetics, topical medicines, fragrances, pesticides, cleaning residue and dirt should not be treated as irrelevant merely because they are absent from the DMSO label. A cream containing several botanical extracts also cannot be assessed as though DMSO were its only ingredient.

Do not substitute industrial or veterinary DMSO for a product intended for human use. Do not improvise a cream by mixing DMSO into moisturizer or medicine: the resulting concentration, compatibility, stability and absorption are unknown. For clinician-directed topical use, follow the specific product instructions rather than a universal internet routine. Our guide to applying DMSO to skin covers contamination and co-exposure concerns.

Side effects are not limited to odor

A systematic review included 109 human studies using DMSO by several routes. Gastrointestinal and skin reactions were the most commonly reported categories; most were transient, and the review found that adverse reactions increased with dose. Reported skin effects included burning or stinging, dryness or scaling, redness, itching, rash, blistering and contact dermatitis (Madsen et al., 2018). Because the studies covered different routes, doses and clinical settings, they do not provide a single side-effect rate for retail DMSO cream.

Garlic-like breath or body odor can occur because DMSO is metabolized partly to dimethyl sulfide. The RIMSO-50 label also notes that DMSO is absorbed after topical application and that dimethyl sulfide is eliminated through breath and skin (DailyMed). Odor is not proof that a cream is pure, effective or harmless.

Stop using a topical product and obtain medical advice for marked burning, persistent redness, blistering or a spreading rash. Facial swelling, breathing difficulty or other signs of a serious allergic reaction require urgent care.

The prescription label reports occasional hypersensitivity with topical DMSO, possible effects on concomitant medicines, inadequate controlled studies in pregnancy, caution while nursing, and no established safety or effectiveness in children. These statements come from the RIMSO-50 bladder-product label, not a trial of retail cream, but they undermine any assumption that unsupervised topical exposure is risk-free (DailyMed).

What to check before buying

Before considering a DMSO cream, look for clear answers to these questions:

• What is the DMSO concentration, and is the percentage by weight or volume?
• Are all active and inactive ingredients disclosed?
• Is the product explicitly intended for human topical use?
• Does the listing identify a responsible manufacturer or distributor, lot number and expiration date?
• Are storage directions, tamper evidence and a way to report adverse events provided?
• Is any purity or test document current, tied to the named product or batch, and issued by an identifiable laboratory?
• Are treatment claims limited, or does the seller imply that one cream treats unrelated diseases?

A complete label still does not show that the cream is suitable during pregnancy, for a child, on broken or diseased skin, or alongside prescriptions and other topicals. A pharmacist or clinician can assess those circumstances and help identify a treatment supported for the actual cause of the pain or skin problem.

Bottom line: DMSO cream is not one standardized treatment. For common joint pain, the available clinical evidence does not establish dependable, meaningful relief. Concentration, cream base, added ingredients, skin condition and nearby substances all affect exposure. A vague label or a long list of cure claims is a reason to pass, not a reason to experiment.